麦克森McKesson Corporation (MCK) 2012年年度报告「NYSE」.pdf

1、Annual ReportFiscal Year Ended March 31,2012201220112010200920082007McKESSON CORPORATIONS&P 500 INDEXVALUE LINE HEALTH CARE INDEX$139.72$156.68$114.92$60.73$89.81$100.00*Assumes$100 invested in McKessons common stock and in each index on March 31,2007,and that all dividends are reinvested.Financial

2、Results20122008$101.7$122.721%INCREASE2008$3.53$6.3881%INCREASE2012Total Revenue (in billions)Adjusted EPS*Five-Year Cumulative Total Return*McKesson grew revenues to a record$122.7 billion,an increase of 10%.Full-year adjusted earnings per diluted share was$6.38*,up 20%,and cash flow from operation

3、s totaled$2.9 billion.We ended fiscal year 2012 with cash and cash equivalents of$3.1 billion,providing the financial strength and flexibility to make investments that position us for future growth.Distribution Solutions fueled our strong performance,with revenues for the segment up 10%and adjusted

4、operating profit up 13%*.U.S.pharmaceutical distribution revenues also increased 10%,reflecting market growth and new business with existing customers.We are particularly proud that the Department of Veterans Affairs renewed its distribution agreement with McKesson,enabling us to continue serving ou

5、r nations veterans.Across the distribution segment,we enhanced our value to customers through our unmatched service levels,global sourcing capabilities and customized solution offerings.In Technology Solutions,we increased revenues 4%to$3.3 billion and grew adjusted operating profit by 21%*.We conti

6、nued toexpand our solution set for hospitals and health systems,payers,pharmacies and physician practices,with a focus on helping them use information technology to address their financial,clinical and integration needs.We are working closely with our customers in all markets to help them prepare fo